Evidence map›Paper›PMID 39695927›Full record

ArticleBMC bioinformatics2024

Loop-mediated isothermal amplification assays for the detection of antimicrobial resistance elements in Vibrio cholera.

Daniel Antonio Negrón, Shipra Trivedi, Nicholas Tolli, David Ashford, Gabrielle Melton, Stephanie Guertin, Katharine Jennings, Bryan D Necciai, Shanmuga Sozhamannan, Bradley W Abramson

Abstract read
In one paragraph

Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel Antonio NegrónNoblis, Inc., 2002 Edmund Halley Dr, Reston, VA, 20191, USA.
Shipra TrivediNoblis, Inc., 2002 Edmund Halley Dr, Reston, VA, 20191, USA.
Nicholas TolliNoblis ESI, 14425 Penrose Pl, Chantilly, VA, 20151, USA.
David AshfordNoblis ESI, 14425 Penrose Pl, Chantilly, VA, 20151, USA.
Gabrielle MeltonNoblis, Inc., 2002 Edmund Halley Dr, Reston, VA, 20191, USA.
Stephanie GuertinNoblis ESI, 14425 Penrose Pl, Chantilly, VA, 20151, USA.
Katharine JenningsNoblis, Inc., 2002 Edmund Halley Dr, Reston, VA, 20191, USA.
Bryan D NecciaiJoint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB), Frederick, MD, 21702, USA.
Shanmuga SozhamannanJoint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB), Frederick, MD, 21702, USA.
Bradley W AbramsonNoblis, Inc., 2002 Edmund Halley Dr, Reston, VA, 20191, USA. Bradley.Abramson@noblis.org.

Funding

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) W911SR-22-C-0049
6 · The paper itself

Abstract

backgroundThe bacterium Vibrio cholerae causes diarrheal illness and can acquire genetic material leading to multiple drug resistance (MDR). Rapid detection of resistance-conferring mobile genetic elements helps avoid the prescription of ineffective antibiotics for specific strains. Colorimetric loop-mediated isothermal amplification (LAMP) assays provide a rapid and cost-effective means for detection at point-of-care since they do not require specialized equipment, require limited expertise to perform, and can take less than 30 min to perform in resource limited regions. LAMP output is a color change that can be viewed by eye, but it can be difficult to design primer sets, determine target specificity, and interpret subjective color changes.

methodsWe developed an algorithm for the in silico design and evaluation of LAMP assays within the open-source PCR Signature Erosion Tool (PSET) and a computer vision application for the quantitative analysis of colorimetric outputs. First, Primer3 calculates LAMP primer sequence candidates with settings based on GC-content optimization. Next, PSET aligns the primer sequences of each assay against large sequence databases to calculate sufficient sequence similarity, coverage, and primer arrangement to the intended taxa, ultimately generating a confusion matrix. Finally, we tested assay candidates in the laboratory against synthetic constructs.

resultsAs an example, we generated new LAMP assays targeting drug resistance in V. cholerae and evaluated existing ones from the literature based on in silico target specificity and in vitro testing. Improvements in the design and testing of LAMP assays, with heightened target specificity and a simple analysis platform, increase utility for in-field applications. Overall, 9 of the 16 tested LAMP assays had positive signal through visual and computer vision-based detection methods developed here. Here we show LAMP assays tested on synthetic AMR gene targets for aph(6), varG, floR, qnrVC5, and almG, which allow for resistance to aminoglycosides, penicillins, carbapenems, phenicols, fluoroquinolones, and polymyxins respectively.

Indexed as

Nucleic Acid Amplification TechniquesVibrio choleraeAlgorithmsCholeraColorimetryDNA PrimersDrug Resistance, BacterialHumansMolecular Diagnostic TechniquesDNA PrimersAMRAntimicrobial resistanceAssayColorimetricComputer visionImage processingLAMPLoop-mediated isothermal amplificationMolecular diagnosticVibrio cholera

Identifiers

PMID39695927
PMCPMC11657800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.